Literature DB >> 3935068

Dissociation between cerebral autoregulation and carbon dioxide reactivity during nonpulsatile cardiopulmonary bypass.

T Lundar, K F Lindegaard, T Frøysaker, R Aaslid, A Grip, H Nornes.   

Abstract

Five patients undergoing cardiopulmonary bypass (CPB) procedures were extensively monitored because of anticipated high risk for neurological complications. Arterial blood pressure (BP), central venous pressure, and epidural intracranial pressure (EDP) were continuously recorded throughout CPB; thus, information on the cerebral perfusion pressure (CPP) was also continuously available (CPP = BP - EDP). Cerebral electrical activity was recorded by a cerebral function monitor. The flow velocity in the middle cerebral artery (MCA) was recorded using a transcranial Doppler technique. During steady-state CPB (constant hematocrit, constant temperature, and constant flow from the heart-lung machine) partial pressure of arterial carbon dioxide (PaCO2) was repeatedly changed to study the effect of changes in this variable on MCA flow velocity during nonpulsatile bypass. During CPB with constant temperature, hematocrit, and PaCO2, the effect of changes in CPP on MCA flow velocity was recorded and analyzed. During nonpulsatile, moderately hypothermic (28 degrees to 32 degrees C), low-flow (1.5 L/min/m2) CPB, there was no evidence of cerebral autoregulation, with CPP levels ranging from 20 to 60 mm Hg. The CO2 reactivity, however, was clearly present and in the range of 1.9 to 4.1%/mm Hg, indicating that there was a dissociation between cerebral autoregulation and CO2 reactivity under these circumstances.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3935068     DOI: 10.1016/s0003-4975(10)60353-0

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  8 in total

1.  Cerebrovascular hemodynamics, gait, and falls in an elderly population: MOBILIZE Boston Study.

Authors:  F A Sorond; A Galica; J M Serrador; D K Kiely; I Iloputaife; L A Cupples; L A Lipsitz
Journal:  Neurology       Date:  2010-05-18       Impact factor: 9.910

Review 2.  Pathophysiology of cardiopulmonary bypass.

Authors:  J M Murkin
Journal:  Can J Anaesth       Date:  1989-05       Impact factor: 5.063

3.  Bolus arrival time and cerebral blood flow responses to hypercarbia.

Authors:  Manus J Donahue; Carlos C Faraco; Megan K Strother; Michael A Chappell; Swati Rane; Lindsey M Dethrage; Jeroen Hendrikse; Jeroen C W Siero
Journal:  J Cereb Blood Flow Metab       Date:  2014-04-30       Impact factor: 6.200

4.  Cerebral perfusion during major cardiac surgery in children.

Authors:  T Lundar; H Lindberg; K F Lindegaard; S Tjønneland; R Rian; G Bø; H Nornes
Journal:  Pediatr Cardiol       Date:  1987       Impact factor: 1.655

Review 5.  Clinical relevance of cerebral autoregulation following subarachnoid haemorrhage.

Authors:  Karol P Budohoski; Marek Czosnyka; Peter J Kirkpatrick; Peter Smielewski; Luzius A Steiner; John D Pickard
Journal:  Nat Rev Neurol       Date:  2013-02-19       Impact factor: 42.937

Review 6.  Measuring cerebrovascular reactivity: what stimulus to use?

Authors:  J Fierstra; O Sobczyk; A Battisti-Charbonney; D M Mandell; J Poublanc; A P Crawley; D J Mikulis; J Duffin; J A Fisher
Journal:  J Physiol       Date:  2013-09-30       Impact factor: 5.182

7.  Arterio-jugular differences of oxygen (AVDO2) for bedside assessment of CO2-reactivity and autoregulation in the acute phase of severe head injury.

Authors:  J Sahuquillo; M A Poca; A Ausina; M Báguena; R M Gracia; E Rubio
Journal:  Acta Neurochir (Wien)       Date:  1996       Impact factor: 2.216

Review 8.  Ultrasound and dynamic functional imaging in vascular cognitive impairment and Alzheimer's disease.

Authors:  Branko Malojcic; Panteleimon Giannakopoulos; Farzaneh A Sorond; Elsa Azevedo; Marina Diomedi; Janja Pretnar Oblak; Nicola Carraro; Marina Boban; Laszlo Olah; Stephan J Schreiber; Aleksandra Pavlovic; Zsolt Garami; Nantan M Bornstein; Bernhard Rosengarten
Journal:  BMC Med       Date:  2017-02-09       Impact factor: 8.775

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.